On rare occasions benzocaine has produced methemoglobinemia from oral, rect
al and dermal exposures. There is disagreement whether this is an idiosyncr
atic event or a dose-related event. To gain a better perspective on this pr
oblem we retrospectively reviewed cases at 4 large regional poison centers
of children <18-y of age from 1993-1996. One hundred and eighty-eight benzo
caine exposures were reported. Mean and median ingested dosage were 86.8 (/- 89.5) mg/kg and 50 mg/kg, respectively. Fifty-eight patients (30%) were
managed in the emergency department: 8 patients had methemoglobin levels de
termined. One child had a methemoglobin level of 19%; all others were <1%.
One hundred and seventy-three patients (92%) remained asymptomatic. Other s
ymptoms were minor: oral numbness (8), vomiting (3), and I each of oral irr
itation, dizziness and nausea. In this series of accidental ingestions of b
enzocaine containing products cyanosis was Fare and apparently not dose rel
ated. These cases may be safely managed at home with telephone follow up fo
r at least 2 h. If there is evidence of cyanosis, dusky pallor, shortness o
f breath, or change in mental status direct medical evaluation should be re
commended.